Apolipoprotein E-deficient mice develop an anti-Chlamydophila pneumoniae T helper 2 response and resist vascular infection.

BACKGROUND Hypercholesterolemia could inhibit the immune response against various pathogens. No information is available about its impact on the immune response toward Chlamydophila pneumoniae. METHODS Apolipoprotein E (apoE)-deficient and wild-type mice fed a normal diet were infected with a single intranasal inoculation of viable C. pneumoniae. RESULTS Whereas interferon gamma concentrations (T helper 1 response) were similar in the lungs and spleen of apoE-deficient and wild-type mice, increased concentrations of interleukin 10, interleukin 6, and interleukin 4 (T helper 2 response) were found in the lungs of apoE-deficient mice. The spleen B lymphocyte percentage and interleukin 4 levels and serum specific antibody titers were higher in apoE-deficient mice. C. pneumoniae infection was facilitated neither in the lungs nor in the aorta of these mice. On the contrary, the number of apoE-deficient mice with detectable levels of bacterial DNA in the aorta was clearly decreased. When low-density lipoprotein receptor-deficient mice fed a normal diet were similarly infected, no difference in the interleukin 4 concentration and infection level was observed in the lungs and no protection was found in the aorta. CONCLUSIONS Mild hypercholesterolemia in mice does not facilitate C. pneumoniae persistence in the vascular wall. ApoE deficiency, rather than mild hypercholesterolemia, probably favors the development of an unusual anti-C. pneumoniae T helper 2 response and protects against vascular infection.

[1]  T. Tsubata,et al.  The Development and Function of Regulatory B Cells Expressing IL-10 (B10 Cells) Requires Antigen Receptor Diversity and TLR Signals1 , 2009, The Journal of Immunology.

[2]  T. Tedder,et al.  Regulatory B cells as inhibitors of immune responses and inflammation , 2008, Immunological reviews.

[3]  C. Leclerc,et al.  Regulatory B and T cells in infections. , 2008, Microbes and infection.

[4]  G. Martens,et al.  Hypercholesterolemia Impairs Immunity to Tuberculosis , 2008, Infection and Immunity.

[5]  S. Pillai,et al.  Peripheral B cell subsets. , 2008, Current opinion in immunology.

[6]  C. Leclerc,et al.  Type I interferons protect neonates from acute inflammation through interleukin 10–producing B cells , 2007, The Journal of experimental medicine.

[7]  D. Rader,et al.  Apolipoprotein E Suppresses the Type I Inflammatory Response In Vivo , 2005, Circulation research.

[8]  L. Bockenstedt,et al.  Infection-Induced Marginal Zone B Cell Production of Borrelia hermsii-Specific Antibody Is Impaired in the Absence of CD1d 1 , 2005, The Journal of Immunology.

[9]  D. Grainger,et al.  Apolipoprotein E Modulates Clearance of Apoptotic Bodies In Vitro and In Vivo, Resulting in a Systemic Proinflammatory State in Apolipoprotein E-Deficient Mice1 , 2004, The Journal of Immunology.

[10]  D. Ojcius,et al.  Chlamydia and apoptosis: life and death decisions of an intracellular pathogen , 2004, Nature Reviews Microbiology.

[11]  M. Netea,et al.  Apolipoprotein-E-deficient mice exhibit an increased susceptibility to disseminated candidiasis. , 2004, Medical mycology.

[12]  L. Jacobs,et al.  Chlamydia pneumoniae stimulates IFN-gamma synthesis through MyD88-dependent, TLR2- and TLR4-independent induction of IL-18 release. , 2004, Journal of immunology.

[13]  Eran Leitersdorf,et al.  Atherosclerosis in the apolipoprotein-E-deficient mouse: a decade of progress. , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[14]  B. Strandvik,et al.  Severe Hypercholesterolaemia Leads to Strong Th2 Responses to an Exogenous Antigen , 2004, Scandinavian journal of immunology.

[15]  A. Rothfuchs,et al.  Macrophages, CD4+ or CD8+ Cells Are Each Sufficient for Protection against Chlamydia pneumoniae Infection through their Ability to Secrete IFN-γ1 , 2004, The Journal of Immunology.

[16]  S. Ouellette,et al.  Chlamydia pneumoniae and atherosclerosis , 2004, Cellular microbiology.

[17]  T. Hackstadt,et al.  Golgi-dependent transport of cholesterol to the Chlamydia trachomatis inclusion , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[18]  M. D’Elios,et al.  T helper type 1 lymphocytes drive inflammation in human atherosclerotic lesions , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[19]  M. Rosenfeld,et al.  Foam Cell Formation Inhibits Growth of Chlamydia pneumoniae but Does Not Attenuate Chlamydia pneumoniae–Induced Secretion of Proinflammatory Cytokines , 2002, Circulation.

[20]  M. Rosenfeld,et al.  Chlamydia pneumoniae infection and atherosclerosis: methodological considerations. , 2002, Circulation.

[21]  S. Ouellette,et al.  Chlamydia trachomatis Persistence in the Female Mouse Genital Tract: Inducible Nitric Oxide Synthase and Infection Outcome , 2001, Infection and Immunity.

[22]  G. Hansson,et al.  Chlamydia pneumoniae Infection Does Not Induce or Modify Atherosclerosis in Mice , 2001, Circulation.

[23]  KatriinaAalto-Setälä,et al.  Chlamydia pneumoniae Does Not Increase Atherosclerosis in the Aortic Root of Apolipoprotein E–Deficient Mice , 2001 .

[24]  R. Zinkernagel,et al.  Hypercholesterolemia Exacerbates Virus-Induced Immunopathologic Liver Disease Via Suppression of Antiviral Cytotoxic T Cell Responses1 , 2001, The Journal of Immunology.

[25]  S. Swain,et al.  Reciprocal regulation of polarized cytokine production by effector B and T cells , 2000, Nature Immunology.

[26]  P. Roholl,et al.  Chlamydia pneumoniae antigens, rather than viable bacteria, persist in atherosclerotic lesions , 2000, Journal of clinical pathology.

[27]  S. Caspar-Bauguil,et al.  Chlamydia pneumoniae induces interleukin-10 production that down-regulates major histocompatibility complex class I expression. , 2000, The Journal of infectious diseases.

[28]  Stalenhoef,et al.  Apolipoprotein E‐deficient mice have an impaired immune response to Klebsiella pneumoniae , 2000, European journal of clinical investigation.

[29]  M. Rosenfeld,et al.  Mouse models of C. pneumoniae infection and atherosclerosis. , 2000, The Journal of infectious diseases.

[30]  G. Hansson,et al.  The Role of Adaptive Immunity in Atherosclerosis , 2000, Annals of the New York Academy of Sciences.

[31]  V. Levitsky,et al.  Regulation and Role of IFN-γ in the Innate Resistance to Infection with Chlamydia pneumoniae1 , 2000, The Journal of Immunology.

[32]  D. Schmechel,et al.  Altered immune responses in apolipoprotein E-deficient mice. , 2000, Journal of lipid research.

[33]  G. Byrne,et al.  Chlamydia pneumoniae and atherosclerosis: links to the disease process. , 1999, American heart journal.

[34]  M. Rosenfeld,et al.  Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. , 1999, The Journal of infectious diseases.

[35]  H. Wigzell,et al.  Role of innate and adaptive immunity in the outcome of primary infection with Chlamydia pneumoniae, as analyzed in genetically modified mice. , 1999, Journal of immunology.

[36]  A. Daugherty,et al.  Apolipoprotein E-deficient mice have impaired innate immune responses to Listeria monocytogenes in vivo. , 1998, Journal of lipid research.

[37]  T. Quinn,et al.  Identification of Chlamydia pneumoniae by DNA amplification of the 16S rRNA gene , 1992, Journal of clinical microbiology.

[38]  N. Therville,et al.  Interleukin-6 deficiency fails to prevent chronic rejection after aortic allografts in apolipoprotein E-deficient mice. , 2009, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[39]  M. Ravaoarinoro,et al.  Chlamydia trachomatis persistence: an update. , 2006, Microbiological research.

[40]  A. Nègre-Salvayre,et al.  Chlamydia pneumoniae alters mildly oxidized low-density lipoprotein-induced cell death in human endothelial cells, leading to necrosis rather than apoptosis. , 2006, The Journal of infectious diseases.

[41]  L. Mannonen,et al.  IFN-gamma induced persistent Chlamydia pneumoniae infection in HL and Mono Mac 6 cells: characterization by real-time quantitative PCR and culture. , 2004, Microbial pathogenesis.

[42]  C. Merril,et al.  Chlamydia pneumoniae Secretion of a Protease-Like Activity Factor for Degrading Host Cell Transcription Factors Required for Major Histocompatibility Complex Antigen Expression , 2002 .